Business Context and Reporting Period
This Form 8-K is a current report filed by Tharimmune, Inc. (not Canton Strategic Holdings, Inc.) on November 7, 2025. The registrant is a Delaware corporation with its principal executive offices in Red Bank, NJ, and its common stock trades on The Nasdaq Stock Market under the symbol THAR. The company is classified as an emerging growth company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The primary material change reported is the appointment of Sireesh Appajosyula as Interim Chief Financial Officer, effective November 7, 2025. This appointment is for a period not to extend beyond December 31, 2025. Mr. Appajosyula's previously disclosed employment agreement with the company remains in effect.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, specific risks, contingencies, or unusual items. The document is limited to the disclosure of the interim CFO appointment under Item 5.02.
Investor Verification Checklist
- Verify the exact terms and duration of Sireesh Appajosyula's interim CFO role.
- Confirm the status of the previously disclosed employment agreement referenced in the filing.
- Monitor for subsequent filings regarding the permanent CFO search or extension of the interim role beyond December 31, 2025.
- Note the discrepancy between the requested company name (Canton Strategic Holdings) and the actual registrant (Tharimmune, Inc.).